The global thin film drug market is expected to grow at a CAGR of 6.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for oral thin films and transdermal thin films in various applications such as hospital pharmacies, drug stores, retail pharmacies, and commerce. The oral thin film segment is expected to grow at a CAGR of 7.2% during the forecast period due to its advantages such as ease of administration and convenience in use. The transdermal thin film segment is expected to grow at a CAGR of 5.8% during the forecast period due to its advantages such as easy absorption and reduced side effects when compared with other dosage forms like tablets or capsules.
The global thin film drug market by type can be classified into oral thin films and transdermal thin films which are further classified into various applications including hospital pharmacies, drug stores, retail pharmacies, commerce etc, based on their application type; North America dominates this market followed by Europe while Asia Pacific region has been witnessing significant growth over the past few years owing to increased awareness about healthcare products among people in these regions; Latin America region will witness significant growth over the next few years owing to increasing awareness about healthcare products among people in these regions; Middle East & Africa region will witness significant growth over the next few years owing to increasing awareness about healthcare products among people in these regions.
Some Of The Growth Factors Of This Market:
- Increasing prevalence of chronic diseases such as diabetes and cancer is driving the growth of the global Thin Film Drug market.
- Increasing awareness about health benefits associated with consumption of natural products is also driving the growth of the global Thin Film Drug market.
- The high cost associated with production and distribution are restraining factors for the growth of this market, which can be overcome by technological advancements in drug delivery systems that will reduce costs significantly over time.
Industry Growth Insights published a new data on “Thin Film Drug Market”. The research report is titled “Thin Film Drug Market research by Types (Oral Thin Film, Transdermal Thin Film, Others), By Applications (Hospital Pharmacies, Drug Stores, Retail Pharmacies, E- Commerce), By Players/Companies ZIM Laboratories Limited, Indivior, MonoSol Rx Allergan, Sumitomo Dainippon Pharma, IntelGenx, Pfizer, Novartis AG, Allergan, NAL Pharma, Wolters Kluwer, Solvay”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Thin Film Drug Market Research Report
By Type
Oral Thin Film, Transdermal Thin Film, Others
By Application
Hospital Pharmacies, Drug Stores, Retail Pharmacies, E- Commerce
By Companies
ZIM Laboratories Limited, Indivior, MonoSol Rx Allergan, Sumitomo Dainippon Pharma, IntelGenx, Pfizer, Novartis AG, Allergan, NAL Pharma, Wolters Kluwer, Solvay
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Thin Film Drug Market Report Segments:
The global Thin Film Drug market is segmented on the basis of:
Types
Oral Thin Film, Transdermal Thin Film, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Drug Stores, Retail Pharmacies, E- Commerce
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ZIM Laboratories Limited
- Indivior
- MonoSol Rx Allergan
- Sumitomo Dainippon Pharma
- IntelGenx
- Pfizer
- Novartis AG
- Allergan
- NAL Pharma
- Wolters Kluwer
- Solvay
Highlights of The Thin Film Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral Thin Film
- Transdermal Thin Film
- Others
- By Application:
- Hospital Pharmacies
- Drug Stores
- Retail Pharmacies
- E- Commerce
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Thin Film Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Thin film drug is a type of medication that is delivered to the body through a thin layer of material. This allows the medication to bypass the digestive system and enter directly into the bloodstream, which can lead to faster delivery to where it is needed most.
Some of the key players operating in the thin film drug market are ZIM Laboratories Limited, Indivior, MonoSol Rx Allergan, Sumitomo Dainippon Pharma, IntelGenx, Pfizer, Novartis AG, Allergan, NAL Pharma, Wolters Kluwer, Solvay.
The thin film drug market is expected to register a CAGR of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Thin Film Drug Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Thin Film Drug Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Thin Film Drug Market - Supply Chain
4.5. Global Thin Film Drug Market Forecast
4.5.1. Thin Film Drug Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Thin Film Drug Market Size (000 Units) and Y-o-Y Growth
4.5.3. Thin Film Drug Market Absolute $ Opportunity
5. Global Thin Film Drug Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Thin Film Drug Market Size and Volume Forecast by Type
5.3.1. Oral Thin Film
5.3.2. Transdermal Thin Film
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Thin Film Drug Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Thin Film Drug Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Drug Stores
6.3.3. Retail Pharmacies
6.3.4. E- Commerce
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Thin Film Drug Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Thin Film Drug Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Thin Film Drug Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Thin Film Drug Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Thin Film Drug Demand Share Forecast, 2019-2026
9. North America Thin Film Drug Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Thin Film Drug Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Thin Film Drug Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Drug Stores
9.4.3. Retail Pharmacies
9.4.4. E- Commerce
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Thin Film Drug Market Size and Volume Forecast by Type
9.7.1. Oral Thin Film
9.7.2. Transdermal Thin Film
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Thin Film Drug Demand Share Forecast, 2019-2026
10. Latin America Thin Film Drug Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Thin Film Drug Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Thin Film Drug Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Drug Stores
10.4.3. Retail Pharmacies
10.4.4. E- Commerce
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Thin Film Drug Market Size and Volume Forecast by Type
10.7.1. Oral Thin Film
10.7.2. Transdermal Thin Film
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Thin Film Drug Demand Share Forecast, 2019-2026
11. Europe Thin Film Drug Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Thin Film Drug Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Thin Film Drug Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Drug Stores
11.4.3. Retail Pharmacies
11.4.4. E- Commerce
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Thin Film Drug Market Size and Volume Forecast by Type
11.7.1. Oral Thin Film
11.7.2. Transdermal Thin Film
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Thin Film Drug Demand Share, 2019-2026
12. Asia Pacific Thin Film Drug Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Thin Film Drug Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Thin Film Drug Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Drug Stores
12.4.3. Retail Pharmacies
12.4.4. E- Commerce
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Thin Film Drug Market Size and Volume Forecast by Type
12.7.1. Oral Thin Film
12.7.2. Transdermal Thin Film
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Thin Film Drug Demand Share, 2019-2026
13. Middle East & Africa Thin Film Drug Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Thin Film Drug Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Thin Film Drug Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Drug Stores
13.4.3. Retail Pharmacies
13.4.4. E- Commerce
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Thin Film Drug Market Size and Volume Forecast by Type
13.7.1. Oral Thin Film
13.7.2. Transdermal Thin Film
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Thin Film Drug Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Thin Film Drug Market: Market Share Analysis
14.2. Thin Film Drug Distributors and Customers
14.3. Thin Film Drug Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. ZIM Laboratories Limited
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Indivior
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. MonoSol Rx Allergan
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Sumitomo Dainippon Pharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. IntelGenx
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Pfizer
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Novartis AG
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Allergan
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. NAL Pharma
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Wolters Kluwer
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Solvay
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
